Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.50 by 5.16 percent. This is a 8.16 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $316.964 million which beat the analyst consensus estimate of $316.004 million by 0.30 percent. This is a 3.55 percent increase over sales of $306.098 million the same period last year.